Gene: C6orf47
Official Full Name: chromosome 6 open reading frame 47provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19248 | C6orf47 Knockout cell line (HeLa) | Human | C6orf47 | 1:3~1:6 | Negative | Online Inquiry |
KO19249 | C6orf47 Knockout cell line (HCT 116) | Human | C6orf47 | 1:2~1:4 | Negative | Online Inquiry |
KO19250 | C6orf47 Knockout cell line (HEK293) | Human | C6orf47 | 1:3~1:6 | Negative | Online Inquiry |
KO19251 | C6orf47 Knockout cell line (A549) | Human | C6orf47 | 1:3~1:4 | Negative | Online Inquiry |
C6orf47 Gene Knockout Cell Lines are specially engineered cellular models that lack the expression of the C6orf47 gene, which is involved in various biological processes such as cell signaling, differentiation, and immune responses. These cell lines are generated using advanced CRISPR/Cas9 gene-editing technology that allows precise modification of specific genomic sequences, effectively creating a knockout that facilitates in-depth study of the gene’s functional consequences.
These cell lines serve multiple key functions in research. By providing a platform to study the loss-of-function phenotype associated with C6orf47, researchers can dissect its role in cellular processes, disease mechanisms, and potential therapeutic targets. The characterization of C6orf47 knockout cells can elucidate pathways involved in several conditions, including cancer and autoimmune disorders, making these models integral to both fundamental biological research and translational applications.
The scientific importance of C6orf47 Gene Knockout Cell Lines lies in their utility for understanding complex genomic interactions and protein functions. They can be applied in functional genomics studies, drug discovery, and testing the efficacy of novel therapeutic compounds in a controlled environment. Furthermore, these cell lines contribute significantly to predictive toxicology assessments, aiding the selection of safe and effective pharmacological agents.
Compared to alternative models, such as chemically induced knockouts or RNA interference approaches, the C6orf47 knockout models provide a more stable and permanent solution, eliminating the variability associated with transient gene silencing. This results in improved reproducibility of experimental results and enhances the overall reliability of the findings.
For researchers and clinicians, utilizing C6orf47 Gene Knockout Cell Lines translates to accelerated insights and the prospect of devising innovative treatments for diseases linked to this gene. Our company specializes in producing high-quality, well-characterized biological products, ensuring that researchers have access to reliable tools that empower their scientific investigations and clinical advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.